Implementation of post-market surveillance in cervical cancer programmes

Overview

World Health Organization (WHO) recommends that the health care programmes actively contribute to post-market surveillance of the medical devices they are using. Postmarket surveillance provides insight into potential quality, safety and performance issues with the medical devices so manufacturers can re-evaluate the risk/benefit profile and take action when necessary. Although users have no official responsibility for post-market surveillance, most of the information on the experience with the actual use of medical devices comes from users.